DIRTT ENVIRONMENTAL SOLUTION (DRTT)

CA25490H1064 - Common Stock

0.3343  0 (-0.36%)

After market: 0.2849 -0.05 (-14.78%)

Fundamental Rating

1

DRTT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Building Products industry. DRTT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, DRTT is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

DRTT had negative earnings in the past year.
DRTT had a negative operating cash flow in the past year.
In the past 5 years DRTT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: DRTT reported negative operating cash flow in multiple years.

1.2 Ratios

DRTT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 19.67%, DRTT is doing worse than 75.56% of the companies in the same industry.
DRTT's Gross Margin has declined in the last couple of years.
DRTT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.31%
GM growth 5Y-17.09%

0

2. Health

2.1 Basic Checks

DRTT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DRTT has more shares outstanding
The number of shares outstanding for DRTT has been increased compared to 5 years ago.
DRTT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.12, we must say that DRTT is in the distress zone and has some risk of bankruptcy.
DRTT has a Altman-Z score of -1.12. This is amonst the worse of the industry: DRTT underperforms 93.33% of its industry peers.
A Debt/Equity ratio of 8.35 is on the high side and indicates that DRTT has dependencies on debt financing.
The Debt to Equity ratio of DRTT (8.35) is worse than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.35
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC8.43%

2.3 Liquidity

DRTT has a Current Ratio of 1.51. This is a normal value and indicates that DRTT is financially healthy and should not expect problems in meeting its short term obligations.
DRTT's Current ratio of 1.51 is on the low side compared to the rest of the industry. DRTT is outperformed by 82.22% of its industry peers.
A Quick Ratio of 0.89 indicates that DRTT may have some problems paying its short term obligations.
With a Quick ratio value of 0.89, DRTT is not doing good in the industry: 82.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.89

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.97% over the past year.
DRTT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.06%.
Measured over the past years, DRTT shows a decrease in Revenue. The Revenue has been decreasing by -5.31% on average per year.
EPS 1Y (TTM)35.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y-11.42%
Revenue growth 5Y-5.31%
Sales Q2Q%-4.12%

3.2 Future

The Earnings Per Share is expected to grow by 35.11% on average over the next years. This is a very strong growth
DRTT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.38% yearly.
EPS Next Y65.08%
EPS Next 2Y35.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.82%
Revenue Next 2Y2.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

DRTT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRTT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

DRTT's earnings are expected to grow with 35.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.11%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DRTT!.
Industry RankSector Rank
Dividend Yield N/A

DIRTT ENVIRONMENTAL SOLUTION

NASDAQ:DRTT (9/14/2023, 9:21:28 PM)

After market: 0.2849 -0.05 (-14.78%)

0.3343

0 (-0.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap34.92M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 8.35
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.51
Quick Ratio 0.89
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)35.97%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y65.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.06%
Revenue growth 3Y-11.42%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y